(19)
(11)
EP 0 353 262 A1
(12)
(43)
Date of publication:
07.02.1990
Bulletin 1990/06
(21)
Application number:
88910155.0
(22)
Date of filing:
27.10.1988
(51)
International Patent Classification (IPC):
A61K
31/
34
( . )
A61K
31/
415
( . )
A61K
31/
44
( . )
A61K
31/
505
( . )
A61P
1/
02
( . )
A61P
5/
12
( . )
A61P
35/
00
( . )
C07D
401/
12
( . )
A61K
31/
41
( . )
A61K
31/
425
( . )
A61K
31/
445
( . )
A61K
45/
00
( . )
A61P
3/
02
( . )
A61P
19/
10
( . )
A61P
43/
00
( . )
(86)
International application number:
PCT/SE1988/000574
(87)
International publication number:
WO 1989/004178
(
18.05.1989
Gazette 1989/11)
(84)
Designated Contracting States:
AT BE CH DE FR GB IT LI LU NL SE
(30)
Priority:
13.11.1987
SE 19870004436
(71)
Applicant:
Aktiebolaget Hässle
S-431 83 Mölndal (SE)
(72)
Inventor:
H KANSON, Rolf
S-222 36 Lund (SE)
(74)
Representative:
Hjertman, Ivan T.
AB ASTRA Patent and Trade Mark Department
S-151 85 Södertälje
S-151 85 Södertälje (SE)
(54)
NEW THERAPEUTICAL USE OF H 2?-RECEPTOR-BLOCKING COMPOUNDS